Tag:
transparency
Latest Headlines
Latest Headlines
Bill calls for cancer clinical trials results to be reported--or else
Fed up with the lack of transparent clinical trial reporting, U.S. Rep. Tom Reed has introduced a bill that adds new teeth to requirements for trial results to be reported.
GAO report finds some hospitals paying more for devices
Findings from a new Government Accountability Office report are causing some members of Congress to push for greater transparency so hospitals pay a fair price for implantable medical devices (IMDs).
U. of Minnesota surgeon gets warning for not disclosing Medtronic work
A top spine surgeon at the University of Minnesota is speaking out after receiving a "cautionary letter" from the medical school's dean saying he had violated ethics policies by not consistently
NIH's final conflict rules for researchers spur new controversy
From now on, the legions of investigators who look to the National Institutes of Health for research support will have to comply with finalized rules requiring them to detail any financial ties they
Covidien launches compliance resource for HCPs
Earlier this week, Covidien announced the launch of the Conscientious Collaboration, an online resource to promote the importance of ethical, clinically meaningful collaboration between healthcare
Tougher disclosure rules spur flak from biomedical researchers
Biomedical researchers have had plenty of time to ponder the NIH's new and far tougher set of standards on what personal financial information has to be disclosed--and they're not at all happy. The
Medtronic discloses $15.7M in physician payments
Medtronic ( NYSE:MDT ) is now posting annual physician payments that exceed $5,000 on its website as part of a commitment to combat perceived conflict of interest. The disclosure shows that during the
Multaq study raises questions about investigators' objectivity
Can researchers accurately review the safety and efficacy of a new drug without actually analyzing the raw data harvested in clinical trials? The Milwaukee Journal-Sentinel took an in-depth look at
Live from MDMA: Shuren shows off transparency
WASHINGTON, D.C. -- Center for Devices and Radiological Health Director Jeffrey Shuren aimed to reassure attendees of the 16th Medical Device Manufacturers Association meeting Tuesday that the center
FDA proposes controversial release of complete response letters
After a long-simmering controversy over regulatory transparency, an FDA task force has proposed releasing its complete response letters to drug developers as part of a wide-ranging plan to let the
